
    
      Our clinical trial, authorized and controlled by the Government of Bahamas, offer safety data
      and effectiveness that encourage continued research. We will divide the patients into a
      treatment group and into a control group. We will control insulin daly dose, c peptide, A1C
      glycated hemoglobin and specific antibodies. Follow up two years.
    
  